Erectile Dysfunction

Difficulty achieving or maintaining an erection — where PDE5 inhibitors and central agents are used.

Erectile dysfunction splits by mechanism: PDE5 inhibitors (tadalafil, sildenafil) act on blood flow and are the well-established first line, while PT-141 (bremelanotide) acts centrally on desire and arousal — useful where the issue isn't purely vascular.

ED can be an early marker of cardiovascular disease, so it's worth a medical look rather than just sourcing pills. The PDE5 inhibitors are well understood; PT-141 is newer. Educational context, not a prescription.

Compounds researched

Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.

Compound	Type	Why it's relevant
Tadalafil	supplement	Long-acting PDE5 inhibitor; first-line.
Sildenafil	supplement	Classic short-acting PDE5 inhibitor.
PT-141	peptide	Central melanocortin agent for desire/arousal.

Erectile Dysfunction

Difficulty achieving or maintaining an erection — where PDE5 inhibitors and central agents are used.

Compounds researched

Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.

Compound	Type	Why it's relevant
Tadalafil	supplement	Long-acting PDE5 inhibitor; first-line.
Sildenafil	supplement	Classic short-acting PDE5 inhibitor.
PT-141	peptide	Central melanocortin agent for desire/arousal.